Chronic postoperative pain in patients undergoing thoracoscopic surgery
Conditions
Interventions
Esketamine Group (AGroup):The prescription of intravenous self-control analgesia pump contains Esketamine (The remaining drugs are the same as the control group)
control group(BGroup):The prescription of intravenous self-control analgesia pump does not contain Esketamine
Sponsors
Pidu District People’s Hospital, Chengdu
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients who meet the criteria for elective thoracic lobectomy from October 2022 to December 2023 in Pidu District People's Hospital. (1) 18 years old= age = 60 years old; (2) ASAI ~ II grade; (3) Patients who intend to electively undergo thoracoscopic lobectomy.
Exclusion criteria
Exclusion criteria: Exclusion criteria: (1) Combined with serious physical diseases, such as uncontrolled hypertension, coronary heart disease, intracranial vascular malformation, asthma attack, severe liver and kidney dysfunction, etc.; (2) Those with a history of epilepsy; (3) Those with a history of manic episodes; (4) Those who are allergic to the test drug: (5) pregnant and lactating women: (6) Patients with glaucoma; (7) Bipolar disorder, or other mental illnesses or mental retardation; (8) Patients under short-term or long-term influence of alcohol: (9) Patients who have difficulty communicating and patients who are unwilling to cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of postoperative neuropathic pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score during postoperative 24-hour activity;Pain score at rest 24 hours after surgery;EQ5D scale scores and chronic postoperative pain levels at 1 month, 6 months, and 12 months after surgery;Postoperative adverse reactions; | — |
Countries
China
Contacts
Public ContactLi Junxiang
Pidu District People’s Hospital, Chengdu
Outcome results
None listed